D.E. Shaw & Co’s iKang Healthcare Group, Inc. KANG Stock Holding History

D.E. Shaw & Co’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-30,000	Closed	-$438K	–	3641
2017 Q1	$438K	Buy	+30,000	New	+$493K	﹤0.01%	2792

Other funds holding KANG

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

D.E. Shaw & Co's KANG Position: Q2 2017 in Review

D.E. Shaw & Co sold out of iKang Healthcare Group, Inc. (KANG) in Q2 2017, closing a stake of 12,765 shares — an estimated $186K sold.

D.E. Shaw & Co first reported a position in KANG in Q2 2014 and held it in 5 quarters. The position peaked at $639K in Q4 2015. 52 funds tracked by Wall St. Rank hold KANG as of Q2 2017.

D.E. Shaw & Co reported no remaining iKang Healthcare Group, Inc. position as of Q2 2017 after selling out during the quarter.
D.E. Shaw & Co sold 12,765 iKang Healthcare Group, Inc. shares in Q2 2017, an estimated $186K.
D.E. Shaw & Co first reported a position in iKang Healthcare Group, Inc. in Q2 2014 and held it in 5 quarters.
D.E. Shaw & Co's iKang Healthcare Group, Inc. position peaked at $639K in Q4 2015.
52 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q2 2017.

Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.